Life Science Connect

Rewriting the Playbook for Stargardt Disease with Atsena Therapeutics' Shannon Boye, Ph.D.

Jul 30, 2026 · 0:18:09

Listen to Episode

✨ AI Summary

Shannon Boye details Atsena Therapeutics' gene therapy for Stargardt.
Strategy focuses on delivery, dual-vector design, and go/no-go.
Learning from clinical experience to advance new programs.

Guests on This Episode

researcher · 1 podcast appearance

More from Life Science Connect

Getting To A First Product Approval With Celcuity's Brian Sullivan

Aug 17, 2026 · 0:50:20

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Aug 13, 2026 · 0:16:22

Fixing AAV Recovery With Siren Biotechnology’s Nathalie Clément, Ph.D.

Aug 12, 2026 · 0:48:16

Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings

Aug 10, 2026 · 0:50:30

View all episodes →